CoChat

The HUNT study: A population-based cohort for genetic research

Open access
Brumpton, Ben M., Graham, Sarah, Surakka, Ida, Skogholt, Anne Heidi, Løset, Mari, Fritsche, Lars G., Wolford, Brooke, Zhou, Wei, Nielsen, Jonas Bille, Holmen, Oddgeir L., Gabrielsen, Maiken E., Thomas, Laurent, Bhatta, Laxmi, Rasheed, Humaira, Zhang, He, Kang, Hyun Min, Hornsby, Whitney, Moksnes, Marta Riise, Coward, Eivind, Melbye, Mads, Giskeødegård, Guro F., Fenstad, Jørn, Krokstad, Steinar, Næss, Marit, Langhammer, Arnulf, Boehnke, Michael, Abecasis, Gonçalo R., Åsvold, Bjørn Olav, Hveem, Kristian, Willer, Cristen J. · 2022 · Cell Genomics

Published version of a preprint

Cited by 110

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

The Trøndelag Health Study (HUNT) is a population-based cohort of ∼229,000 individuals recruited in four waves beginning in 1984 in Trøndelag County, Norway. Approximately 88,000 of these individuals have available genetic data from array genotyping. HUNT participants were recruited during four community-based recruitment waves and provided information on health-related behaviors, self-reported diagnoses, family history of disease, and underwent physical examinations. Linkage via the Norwegian personal identification number integrates digitized health care information from doctor visits and national health registries including death, cancer and prescription registries. Genome-wide association studies of HUNT participants have provided insights into the mechanism of cardiovascular, metabolic, osteoporotic, and liver-related diseases, among others. Unique features of this cohort that facilitate research include nearly 40 years of longitudinal follow-up in a motivated and well-educated population, family data, comprehensive phenotyping, and broad availability of DNA, RNA, urine, fecal, plasma, and serum samples.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.xgen.2022.100193

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 44

  1. Holmen, 1990, A health survey in Nord-Trøndelag 1984-86. Participation and comparison of attendants and non-attendants, Tidsskr. Nor. Laegeforen., 110, 1973
  2. Holmen, 2003, The Nord-Trøndelag Health Study 1995–97 (HUNT 2): objectives, contents, methods and participation, Norsk epidemiologi, 13, 19
  3. Holmen, 2014, Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk, Nat. Genet., 46, 345, 10.1038/ng.2926 · DOI · Paper page
  4. Holmen, 2014, No large-effect low-frequency coding variation found for myocardial infarction, Hum. Mol. Genet., 23, 4721, 10.1093/hmg/ddu175 · DOI
  5. Liu, 2014, Meta-analysis of gene-level tests for rare variant association, Nat. Genet., 46, 200, 10.1038/ng.2852 · DOI · Paper page
  6. Guo, 2014, Illumina human exome genotyping array clustering and quality control, Nat. Protoc., 9, 2643, 10.1038/nprot.2014.174 · DOI · Paper page
  7. Zhou, 2017, Improving power of association tests using multiple sets of imputed genotypes from distributed reference panels, Genet. Epidemiol., 41, 744, 10.1002/gepi.22067 · DOI
  8. Surakka, 2021, Sex-specific survival bias and interaction modeling in coronary artery disease risk prediction, medRxiv
  9. Feng, 2015, Methods for association analysis and meta-analysis of rare variants in families, Genet. Epidemiol., 39, 227, 10.1002/gepi.21892 · DOI
  10. Zhou, 2018, Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies, Nat. Genet., 50, 1335, 10.1038/s41588-018-0184-y · DOI · Paper page
  11. Zhou, 2020, Scalable generalized linear mixed model for region-based association tests in large biobanks and cohorts, Nat. Genet., 52, 634, 10.1038/s41588-020-0621-6 · DOI · Paper page
  12. Zhou, 2021, Set-based rare variant association tests for biobank scale sequencing data sets, medRxiv
  13. Liu, 2017, Case-control association mapping by proxy using family history of disease, Nat. Genet., 49, 325, 10.1038/ng.3766 · DOI · Paper page
  14. Zhuang, 2021, Incorporating family disease history and controlling case-control imbalance for population based genetic association studies, medRxiv
  15. Surakka, 2020, MEPE loss-of-function variant associates with decreased bone mineral density and increased fracture risk, Nat. Commun., 11, 10.1038/s41467-020-17315-0 · DOI
  16. Rivadeneira, 2009, Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies, Nat. Genet., 41, 1199, 10.1038/ng.446 · DOI · Paper page
  17. Nielsen, 2020, Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease, Nat. Commun., 11, 10.1038/s41467-020-20086-3 · DOI · Paper page
  18. Graham, 2019, Sex-specific and pleiotropic effects underlying kidney function identified from GWAS meta-analysis, Nat. Commun., 10, 10.1038/s41467-019-09861-z · DOI · Paper page
  19. Brumpton, 2019, Variation in serum PCSK9 (proprotein convertase subtilisin/kexin type 9), cardiovascular disease risk, and an investigation of potential unanticipated effects of PCSK9 inhibition, Circ. Genom. Precis. Med., 12, 10.1161/CIRCGEN.118.002335 · DOI
  20. Nielsen, 2018, Genome-wide study of atrial fibrillation identifies seven risk loci and highlights biological pathways and regulatory elements involved in cardiac development, Am. J. Hum. Genet., 102, 103, 10.1016/j.ajhg.2017.12.003 · DOI · Paper page
  21. Moksnes, 2021, Genome-wide association study of cardiac troponin I in the general population, Hum. Mol. Genet., 30, 2027, 10.1093/hmg/ddab124 · DOI
  22. Moksnes, 2021, Genome-wide meta-analysis of iron status biomarkers and the effect of iron on all-cause mortality in HUNT, medRxiv
  23. Howe, 2021, Within-sibship GWAS improve estimates of direct genetic effects, bioRxiv
  24. Rasheed, 2021, The causal effects of serum lipids and apolipoproteins on kidney function: multivariable and bidirectional Mendelian-randomization analyses, Int. J. Epidemiol., 50, 1569, 10.1093/ije/dyab014 · DOI
  25. Zheng, 2022, Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease, Int. J. Epidemiol., 50, 1995, 10.1093/ije/dyab203 · DOI
  26. Stanzick, 2021, Discovery and prioritization of variants and genes for kidney function in >1.2 million individuals, Nat. Commun., 12, 10.1038/s41467-021-24491-0 · DOI · Paper page
  27. Moen, 2020, Mendelian randomization study of maternal influences on birthweight and future cardiometabolic risk in the HUNT cohort, Nat. Commun., 11, 10.1038/s41467-020-19257-z · DOI
  28. Wang, 2021, Investigating a potential causal relationship between maternal blood pressure during pregnancy and future offspring cardiometabolic health, Hypertension, 79, 170, 10.1161/HYPERTENSIONAHA.121.17701 · DOI
  29. Aragam, 2021, Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants, medRxiv
  30. Klarin, 2020, Genetic architecture of abdominal aortic aneurysm in the million veteran program, Circulation, 142, 1633, 10.1161/CIRCULATIONAHA.120.047544 · DOI · Paper page
  31. Boer, 2021, Deciphering osteoarthritis genetics across 826, 690 individuals from 9 populations, Cell, 184, 6003, 10.1016/j.cell.2021.11.003 · DOI
  32. Köttgen, 2020, The CKDGen Consortium: ten years of insights into the genetic basis of kidney function, Kidney Int., 97, 236, 10.1016/j.kint.2019.10.027 · DOI
  33. Bakker, 2020, Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors, Nat. Genet., 52, 1303, 10.1038/s41588-020-00725-7 · DOI · Paper page
  34. Lane, 2019, Biological and clinical insights from genetics of insomnia symptoms, Nat. Genet., 51, 387, 10.1038/s41588-019-0361-7 · DOI · Paper page
  35. John, 2020, Genetic associations and architecture of asthma-chronic obstructive pulmonary disease overlap, medRxiv
  36. Wang, 2019, Genome-wide association analysis of self-reported daytime sleepiness identifies 42 loci that suggest biological subtypes, Nat. Commun., 10
  37. McGuire, 2021, Model-based assessment of replicability for genome-wide association meta-analysis, Nat. Commun., 12, 10.1038/s41467-021-21226-z · DOI
  38. Initiative, 2021, Mapping the human genetic architecture of COVID-19, Nature
  39. Zhou, 2021, Global Biobank Meta-analysis Initiative: powering genetic discovery across human diseases, medRxiv
  40. 2012, An integrated encyclopedia of DNA elements in the human genome, Nature, 489, 57, 10.1038/nature11247 · DOI · Paper page
  41. Li, 2008, Worldwide human relationships inferred from genome-wide patterns of variation, Science, 319, 1100, 10.1126/science.1153717 · DOI · Paper page
  42. Wang, 2014, Ancestry estimation and control of population stratification for sequence-based association studies, Nat. Genet., 46, 409, 10.1038/ng.2924 · DOI · Paper page
  43. Zhang, 2020, Fast and robust ancestry prediction using principal component analysis, Bioinformatics, 36, 3439, 10.1093/bioinformatics/btaa152 · DOI
  44. Green, 2013, ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing, Genet. Med., 15, 565, 10.1038/gim.2013.73 · DOI · Paper page

Cited by

See all 110

Metadata

Authors
Brumpton, B. M., Graham, S., Surakka, I., Skogholt, A. H., Løset, M., Fritsche, L. G., Wolford, B., Zhou, W., Nielsen, J. B., Holmen, O. L., Gabrielsen, M. E., Thomas, L., Bhatta, L., Rasheed, H., Zhang, H., Kang, H. M., Hornsby, W., Moksnes, M. R., Coward, E., Melbye, M., Giskeødegård, G. F., Fenstad, J., Krokstad, S., Næss, M., Langhammer, A., Boehnke, M., Abecasis, G. R., Åsvold, B. O., Hveem, K., & Willer, C. J.
Venue
Cell Genomics
Publisher
Elsevier BV
Published
2022-10
Volume
2
Issue
10
Pages
100193
ISSN
2666-979X (ISSN-L)
OpenAlex
W4304695407
Cited by
110
References
24
FWCI
12.12
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.